Glucose sensor membranes for mitigating the foreign body response
- PMID: 22027297
- PMCID: PMC3208860
- DOI: 10.1177/193229681100500505
Glucose sensor membranes for mitigating the foreign body response
Abstract
Continuous glucose monitoring devices remain limited in their duration of use due to difficulties presented by the foreign body response (FBR), which impairs sensor functionality immediately following implantation via biofouling and leukocyte infiltration. The FBR persists through the life of the implant, culminating with fibrous encapsulation and isolation from normal tissue. These issues have led researchers to develop strategies to mitigate the FBR and improve tissue integration. Studies have often focused on abating the FBR using various outer coatings, thereby changing the chemical or physical characteristics of the sensor surface. While such strategies have led to some success, they have failed to fully integrate the sensor into surrounding tissue. To further address biocompatibility, researchers have designed coatings capable of actively releasing biological agents (e.g., vascular endothelial growth factor, dexamethasone, and nitric oxide) to direct the FBR to induce tissue integration. Active release approaches have proven promising and, when combined with biocompatible coating materials, may ultimately improve the in vivo lifetime of subcutaneous glucose biosensors. This article focuses on strategies currently under development for mitigating the FBR.
© 2011 Diabetes Technology Society.
Figures



References
-
- Wilson GS, Zhang Y. Introduction to the glucose sensing problem. In vivo glucose sensing. In: Cunningham DD, Stenken JA, editors. Hoboken: John Wiley & Sons; 2009.
-
- Anderson JM. Biological responses to materials. Annu Rev Mater Res. 2001;31(1):81–110.
-
- Thomé-Duret V, Gangnerau MN, Zhang Y, Wilson GS, Reach G. Modification of the sensitivity of glucose sensor implanted into subcutaneous tissue. Diabetes Metab. 1996;22(3):174–178. - PubMed
-
- Gerritsen M, Jansen JA, Kros A, Vriezema DM, Sommerdijk NA, Nolte RJ, Lutterman JA, Van Hövell SW, Van der Gaag A. Influence of inflammatory cells and serum on the performance of implantable glucose sensors. J Biomed Mater Res. 2001;54(1):69–75. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical